Progress and perspectives on nanoplatforms for drug delivery to the brain-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Progress and perspectives on nanoplatforms for drug delivery to the brain

Published:2020-06 Issue: Volume:57 Page:101636
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Xu Yingqian,Wei Lijia,Wang Hui

Funder

Chongqing Research Program of Basic Research and Frontier Technology

Chongqing Science and Health Joint Medical Research Project

Chongqing Medical and Pharmaceutical College Research and Innovation Teams Project

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference232 articles.

1. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier;Tam;Int. J. Pharm.,2016

2. Recent progress of drug nanoformulations targeting to brain;Khan;J. Contr. Release,2018

3. Current strategies for brain drug delivery;Dong;Theranostics,2018

4. Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies;Polanco;Nat. Rev. Neurol.,2017

5. Drug candidates in clinical trials for Alzheimer's disease;Hung;J. Biomed. Sci.,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises;International Journal of Biological Macromolecules;2024-10

2. Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification;Current Neuropharmacology;2023-03

3. Blood-Brain Barrier (BBB)-Crossing Strategies for Improved Treatment of CNS Disorders;Handbook of Experimental Pharmacology;2023

4. Emerging nanoformulations for drug targeting to brain through intranasal delivery: A comprehensive review;Journal of Drug Delivery Science and Technology;2022-12

5. Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma;Pharmaceutics;2022-10-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3